View the event
| Reference: | 4451 |
| Country: | Thailand |
| Multiple country event: | No |
| Region: | SEARO |
| City: | Bangkok |
| Start date: | 23 September 2011 |
| End date: | 4 October 2011 |
| Estimated duration: | |
| Status: | Completed - Complété |
| | (The mission has taken place) |
|
| Title: | To conduct preliminary analysis of association between specific molecular genetic basis of drug resistance and TB baseline histo |
| Type: | Mission |
| Terms of Reference: | addition, treatment of drug-resistant tuberculosis can be complicated by the acquisition of additional drug resistances and poor treatment outcome. A number of specific mutations have been identified that confer resistance to first and second line treatment drugs. It is not known whether different mutations with the same phenotypic (in vitro) drug resistance are clinically the same. Novel molecular genetic rapid tests for drug resistance test directly for the most common mutations known to cause drug resistance. |
| Training Opportunity: | No |
| Website: | |
| Purpose 1: | MDR-TB / XDR-TB |
| Purpose 2: | |
| Purpose 3: | |
| Other purpose: | |
|
| Entered by: | Center for Disease Control and Prevention (CDC) |
| Partner 1: | |
| Partner 2: | |
| Partner 3: | |
| Contact name: | Ellie Click |
| Contact email: | gqu3@cdc.gov |
| Other agencies: | |
|
| Funding needs: | No |
| Funding source: | |
| Other funding source: | |
| Available funding: | $ 0 |
| Funding gap: | $ 0 |
| Global Fund reference: | |
|
| Comments: | |
| |
|
Documents associated with this event |
| Mission Report - Rapport de la mission |
This document is not publicly available |
Confidential |
|
There are no experts (roster) associated with this event. There are no experts (non-roster) associated with this event.
Date Created: 19 July 2012
Entered By: CDC
|
